Lipitor has the distinction of being the best-selling prescription medication of all time. Manufactured by pharmaceutical titan company, Pfizer, Lipitor is prescribed to help treat high cholesterol and reduce the risk of heart attacks and strokes. There is no doubt that Lipitor has helped millions of people since it was approved by the FDA in 1996.

However, recent studies have linked Lipitor to an increased risk of developing another serious disease: type 2 diabetes. In 2012, the FDA released a warning that cholesterol-reducing statin drugs, such as Lipitor, could elevate blood sugar levels in those who take it and lead to diabetes. Pfizer was ordered to add this warning on the Lipitor label.

This warning did not help people who had already developed diabetes while taking Lipitor, and it has led to lawsuits regarding inadequate warnings and a decreased quality of life as a result of this failure to warn consumers about all the potential risks.

About Lipitor

Lipitor is a prescription medication known as a “statin” drug, which means it works with the body to help stop the liver from producing too much “bad” cholesterol, which can lead to heart disease and blood clots (which can lead to strokes).

Lipitor was first approved by the FDA in 1996, and by 2012 had made over $130 billion in sales. Doctors continue to prescribe Lipitor and other statin medications today because of their proven track record of helping reduce the risk of heart disease and strokes.

However, there are other risks associated with statin medication, including muscle damage, memory loss and the aforementioned risk of developing diabetes. Doctors are less inclined to direct a patient to stop taking statin medication because of the former two symptoms (since heart disease and strokes are much more serious afflictions), but developing diabetes is obviously problematic also, so good awareness and consistent checkups and blood sugar testing should be standard when taking these medications.

If you developed diabetes while on Lipitor

You may have a good case for financial recompense if you developed type 2 diabetes while taking Lipitor prior to 2012. Whether or not it was known to Pfizer prior to the FDA demanding they place a warning on their bottles of Lipitor, it is still unacceptable that it took so long to find this link between Lipitor and another very serious disease.

Diabetes has life-altering effects on those who are diagnosed, including costly medical appointments, possible dialysis and surgeries, not to mention a complete change in lifestyle in order to constantly monitor their blood sugar levels. Further risks of diabetes include blindness, neuropathy and deadly kidney disease.

Hundreds of lawsuits regarding Lipitor and diabetes have been filed across the country, and the legal professionals at Altman & Altman LLP have the expertise to figure out the appropriate course of action if you or a loved one was diagnosed with diabetes as a result of taking Lipitor or other statin medications.

There are grounds for lawsuits based on negligence, failing to monitor the safety of a prescription medication, misleading consumers of the risks of a medication, inadequately labeling a prescription medication and ignoring potential risks of a prescription medication. Continue reading

The popular heartburn medication Nexium, released by pharmaceutical giant AstraZeneca in 2001, has been used by millions around the globe to treat their chronic heartburn with relatively few side effects. Minor side effects include dry mouth, headaches and minor abdominal pain, which are certainly manageable.

However, more severe side effects have come to light in thousands of patients, side effects undisclosed by AstraZeneca and not mentioned on Nexium’s list of side effect, and hundreds of these patients have filed lawsuits seeking financial compensation for their pain and suffering as a result.

Serious side effects include…

It has been revealed that Nexium can lead to severe kidney complications and even accelerated dementia in its patients. Lawsuits stemming from kidney damage have been filed against AstraZeneca as far back as 2004, and yet they have continued to release the product without mentioning the potential risk of kidney damage. On Nexium’s own website, there is no mention of these well-established risks.

Three studies from 2015 and 2016 showed evidence that patients who were currently taking Nexium were twice as likely to sustain an acute kidney injury, that patients had a 20 to 50 percent higher chance of developing chronic kidney disease, and that patients taking Nexium had a 44 percent higher risk of developing dementia.

Clearly, the risks are not insignificant. These side effects are not only dangerous to a person’s overall health and wellbeing, they can be incredibly costly as well.

Kidney disease sufferers may need to undergo dialysis, transplants or grafts, and will likely maintain consistent hospital visits throughout the rest of their lives to keep an eye on their condition. Kidney failure accounts for about $42.5 billion annually in private and Medicare costs according to the National Institute of Diabetes and Digestive and Kidney Diseases.

Sufferers of dementia can lose their independence, their job, and more, as they may need to be moved into an expensive assisted living facility. Dementia can be extremely painful for both the individual and their families to go through, not to mention the fact that the average assisted living care facility can cost upwards of $70,000 or more per year.

History of legal action

Hundreds of patients who have been negatively affected by Nexium have sought financial recompense as a result of their pain and suffering, both individually and as a group through class action lawsuits. AstraZeneca has been sued over the past decade for negligence, fraud, negligent misrepresentation, and product defects.

Three of these class actions suits were settled in 2015. One ended with a $24 million settlement, another ended with a $20 million settlement, and the last one settled for $7.9 million. More lawsuits are cropping up in recent years with yet another allegation – that Nexium causes bone density loss leading to an increased risk of bone fractures. Continue reading

The FDA has warned that fluoroquinolone antibiotics, including Levaquin and Cipro, are linked to serious, potentially permanent medical conditions. According to reports, manufacturers of these drugs knew about the risks but failed to properly warn physicians and patients. As a result, many lawsuits have been filed. If you are experiencing painful or debilitating side effects after taking a fluoroquinolone, contact your healthcare provider immediately.

What is a Fluoroquinolone Antibiotic?

Fluoroquinolones belong to a family of synthetic antibiotics, which kill bacteria by interfering with the replication of DNA. The types of fluoroquinolones on the market are:

• Ciprofloxacin (Cipro)
• Moxifloxacin (Avelox)
• Levofloxacin (Levaquin/Quixin)
• Ofloxacin (Ocuflox/Floxin/Floxacin)
• Norfloxacin (Noroxin)
• Gatifloxacin (Tequin)

Hospitals routinely use fluoroquinolones for treating opportunistic infections in patients. However, frequent or routine use of this type of antibiotic can have harmful side effects, including tendon damage and nerve damage. According to the FDA, fluoroquinolones should only be used when no other options are available. In addition, physicians should notify patients of the associated risks prior to administering the medication. Considering that most fluoroquinolones are distributed by a pharmacy and that pharmacies are required to provide notification of side effects, the manufacturers are usually held liable when harmful side effects develop. If you are suffering from side effects after taking a fluoroquinolone antibiotic, contact a Boston drug injury lawyer today.

Side Effects Linked to Fluoroquinolones

The fluoroquinolone family is linked to multiple side effects, but the most commonly-cited serious side effects include:

• Nervous system problems, including a condition called peripheral neuropathy, pain, tingling, numbness, weakness, headaches, loss of memory, loss of concentration, and anxiety.

• Musculoskeletal problems, including tendonitis, tendon ruptures, tendon weakness, and swelling of the joints.

• Sensory symptoms, including problems with hearing, sight, and smell.

• Cardiovascular problems, including chest pain, palpitations, and shortness of breath.

• Skin problems, including rashes, intolerance to heat or cold, and excessive sweating.

• Gastrointestinal problems, including nausea and vomiting, diarrhea, and severe abdominal pain.

Continue reading

Proton pump inhibitors (PPIs) are often prescribed as treatment for acid-related conditions because of their ability to block the enzyme in the wall of the stomach that makes acid, thereby decreasing the production of acid in the body.  Examples of some protein pump inhibitors that are often prescribed are omeprazole (Prilosec and Losec), lansoprazole (Prevacid), pantoprazole (Protonix), esomeprazole (Nexium), and a rapid release form of omeprazole (Zegarid).  These medications are used for the prevention and treatment of conditions such as duodenal stomach ulcers, NSAID-associated ulcer, ulcers, heartburn, acid reflux, gastroesophageal reflux disease (GERD) and Zollinger-Ellison syndrome.  In 2013, over 15 million Americans were using these proton pump inhibitors.

There are some common side effects associated with various types of protein pump inhibitors.  Most often, these include headache, diarrhea, constipation, abdominal pain, flatulence, nausea, and rash.  Still, these medications are typically considered to be well tolerated by patients.  Additionally, the risk of Clostridium difficile infection may increase while taking PPIs, and long-term use may increase the risk of osteoporosis-related fractures of the hip, wrist, or spine.  More serious adverse side effects have recently been discovered.  There may be a connection between proton pump inhibitors and long-term kidney damage, a new study published in January shows.  JAMA Internal Medicine published findings that individuals who take proton pump inhibitors have a 20 percent to 50 percent increased risk of chronic kidney disease when compared with individuals who don’t take the drugs.  Although the study does not solidify a causal relationship between PPIs and kidney disease, Dr. Morgan Grams, an assistant professor of epidemiology at Johns Hopkins University and lead author of the study, said, “We found there was an increasing risk associated with an increasing dose. That suggests that perhaps this observed effect is real.”  Continue reading

Inferior vena cava (IVC) filters are blood-filtering devices that are often implanted in people recovering from accidents and surgeries by preventing blood clots from traveling to the lungs.  These devices can be temporary or permanent and are inserted into the largest vein in the body where they trap clots.  By 2012, about 259,000 IVC filters had been inserted into patients.  Doctors typically recommend IVC filters to patients who have recently suffered serious injury or undergone surgery, because they are at an increased risk of blood clots, but cannot take blood thinners.  Those who have just had surgery or a serious injury often cannot take blood thinners because they are at a risk of uncontrollable bleeding, so doctors recommend IVC as an alternative.  Common cases in which doctors might recommend the use of an IVC filter include car accidents, voluntary or emergency surgeries, gunshot or stabbing injuries, dialysis treatment, spinal cord injury, cancer diagnosis or treatment, and serious falls.

The inferior vena cava is the largest vein in the body.  The vein moves deoxygenated blood from the lower legs to the heart and then to the lungs.  IVC filters are specifically used to prevent blood clots from traveling to the lungs, which could result in a pulmonary embolism, a blockage in the lung.  The two types of IVC filters are permanent and optional, or retrievable.  Retrievable IVC filters are often associated with complications including blood vessel and organ perforation, as well as filter migration.  Because of these known potential risks, the U.S. Food and Drug Administration announced a safety alert regarding retrievable IVC filters in 2010.  This report was prompted by 921 reports of adverse events that occurred from 2005 to 2010 as a result of retrievable IVC filters.  Some of these events included device migration, filter perforation, filter fracture, and detached device components.  The most common adverse incident was device migration, accounting for 35 percent of total adverse incidents.  Another problem with retrievable filters is that they are not often removed when they should be.  Follow up studies on retrievable IVC filters performed by the Journal of the American Medical Association (JAMA) found that only 58 of 679 filters that were inserted were actually removed.  Five specific brands of filter prone to failure were Bard’s Recovery, Bard’s G2, Bard’s G2 Express, Cook’s Gunther Tulip, and Cook’s Celect.  Continue reading

Invokana, also known by its generic canagliflozin, is a prescription medication used to control high blood sugar in people who have type 2 diabetes.  Proper diet and exercise is used in collaboration with Invokana to help prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems that can occur from high blood sugar.  Invokana works by signaling your kidneys to remove more sugar from the blood stream.  Invokamet is another prescription drug used to treat type 2 diabetes which is a combination of canagliflozin and metformin.  In addition to increasing the removal of sugar by your kidneys, Invokamet also lowers the amount of sugar made in your liver and decreases how much sugar your body takes in through your stomach and intestines.  Invokana and Invokamet are members of a new class of diabetes medications called sodium-glucose co-transporter 2 (SGLT2) inhibitors.  SGLT2 is a protein in humans that facilitates glucose reabsorption in the kidney.  These inhibitors block this reabsorption, as well as increase glucose excretion, and lower blood glucose levels.  However, these types of diabetes medications have recently been associated with patients developing diabetic ketoacidosis and other complications, leading to many lawsuits.

Lawsuits have been filed against the manufacturers of both Invokana and Invokamet, that being Janssen Pharmaceuticals and its parent company, Johnson & Johnson.  Many of these lawsuits claim that the manufacturers of these drugs failed to warn patients and physicians of the increased risks of kidney failure, heart attacks, and ketoacidosis.  The claim argues that if physicians had known the increased risks, they would have prescribed alternative medications, and patients who did take these drugs also would have been more vigilant about monitoring their health and potentially severe side effects.  The side effects that patients experienced are serious and can be lethal in cases.  Kidney failure is a common complication.  The kidneys are essential to filtering out waste from the blood, controlling blood pressure, balancing electrolytes, and producing red blood cells.  When the kidneys stop working, waste products and electrolytes can build up causing weakness, shortness of breath, lethargy, confusion, abnormal heart rhythms, and sudden death.  Heart attacks were also an alleged side effect of the diabetes medications, a condition in which a blood clot starves part of the heart of oxygen eventually causing the tissue to die.  Continue reading

Inferior vena cava filters, or IVC filters as they’re more commonly known, are used to treat patients with blood-clotting disorders who don’t tolerate more traditional treatments, such as blood thinners. In these special cases, IVC filters can be a life-saving alternative. However, in recent months, IVC filters have been at the center of numerous lawsuits. Concerns about device migration, where the filter moves to other areas of the body, and partial migration, where a piece breaks off and migrates, have resulted in new warnings by the Food and Drug Administration (FDA). So, if you have an IVC filter, should you have it removed? Contact a Boston Defective Medical Products Lawyer Today.

Filters Should Be Removed as Soon as Possible

In response to numerous adverse event reports by patients claiming they were injured by the defective filters, the FDA updated its guidelines for device monitoring and removal. According to the agency, patients with an IVC blood filter should be closely monitored by their physician while the filter remains implanted. Furthermore, filters should be removed as soon as possible, based on the patient’s individual circumstances. In layman’s terms, this means that IVC filters should be removed the moment they are no longer medically necessary. More specifically, the FDA warns that IVC filters should be removed between the 29th and 54th day following implantation.

The Risk of Embolism

The FDA gave special attention to a problem called embolization, in which parts of the filter migrate to the patient’s lungs or heart. This potentially life-threatening condition is of great concern. In addition to the risk of puncturing vital organs and blood vessels, broken and fractured filters are also extremely difficult to remove. When migration and fracture occur, the removal process itself can be risky.

The main culprits in the IVC filter lawsuits are manufacturers Cook Medical and C.R. Bard.

The lawsuits claim defective design, failure to warn, negligence, and breach of implied warranty. In 2010, the FDA received more than 900 adverse event reports related to IVC filters. Included in those reports were 328 device migrations, 146 embolisms, 70 filter perforations, and 56 filter migrations.

Talk to Your Doctor

Long story short, the longer an IVC filter remains in a patient’s body, the higher the patient’s chance of experiencing an adverse event. Every patient’s circumstances are unique, but if you currently have an IVC filter implant, or are getting one, it is in your best interest to discuss the risks with your doctor. Continue reading